Electrostimulation and Electromagnetic Therapy for Wound Treatment
Defines Blue Cross Blue Shield Massachusetts commercial coverage position on electrical stimulation and electromagnetic therapy for wound treatment, applicable to Managed Care (HMO/POS), PPO, and Indemnity products, including prior authorization requirements and relevant coding. The policy classifies these therapies as investigational for wound treatment.
Annual policy review performed 3/2025; policy statements unchanged.
3/2024 annual policy review: references updated; policy statements unchanged.
4/2022 clarified coding language.
Coverage Summary & Determination
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.